EXACT Sciences Corporation Release: Newest Study Of Stool DNA Testing For Colon Cancer Accepted For Publication

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sept. 15, 2006--EXACT Sciences Corporation (NASDAQ:EXAS - News) announced today that the results of a prospective, multi-center study, as set forth in a manuscript entitled "Improved Fecal DNA (fDNA) Test for Colorectal Cancer (CRC) Screening", have been accepted for publication by a major gastroenterology journal. These data were previously reported at the May 2006 annual Digestive Disease Week (DDW) conference, the world's largest meeting of gastroenterology professionals.